↓ Skip to main content

Comparison of conventional versus liposomal irinotecan in combination with fluorouracil for advanced pancreatic cancer: a single-institution experience

Overview of attention for article published in Medical Oncology, September 2019
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (51st percentile)
  • High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

twitter
4 X users

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
16 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Comparison of conventional versus liposomal irinotecan in combination with fluorouracil for advanced pancreatic cancer: a single-institution experience
Published in
Medical Oncology, September 2019
DOI 10.1007/s12032-019-1309-6
Pubmed ID
Authors

Justin C. Tossey, Joshua Reardon, Jeffrey B. VanDeusen, Anne M. Noonan, Kyle Porter, Matthew J. Arango

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 16 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 16 100%

Demographic breakdown

Readers by professional status Count As %
Other 3 19%
Researcher 2 13%
Student > Bachelor 1 6%
Student > Doctoral Student 1 6%
Unknown 9 56%
Readers by discipline Count As %
Medicine and Dentistry 4 25%
Immunology and Microbiology 1 6%
Agricultural and Biological Sciences 1 6%
Unknown 10 63%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 January 2023.
All research outputs
#13,804,446
of 24,115,737 outputs
Outputs from Medical Oncology
#522
of 1,359 outputs
Outputs of similar age
#163,598
of 344,476 outputs
Outputs of similar age from Medical Oncology
#3
of 12 outputs
Altmetric has tracked 24,115,737 research outputs across all sources so far. This one is in the 42nd percentile – i.e., 42% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,359 research outputs from this source. They receive a mean Attention Score of 3.3. This one has gotten more attention than average, scoring higher than 61% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 344,476 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.
We're also able to compare this research output to 12 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 83% of its contemporaries.